These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37837919)

  • 21. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis.
    Qiu L; Weng G
    J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
    Liu T; Yin L; Yan G; Li C; Wang L
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis.
    Liang Q; Jin W; Huang Z; Yin H; Liu S; Liu L; Song X; Wang Z; Fei J
    Front Cell Infect Microbiol; 2023; 13():1125946. PubMed ID: 36926516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis.
    Deswal R; Dang AS
    Fertil Steril; 2020 Mar; 113(3):661-669.e2. PubMed ID: 32192599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis.
    Qiu X; Tang Y; Zou R; Zeng Y; Yue Y; Li W; Qu Y; Mu D
    Sci Rep; 2019 Aug; 9(1):11408. PubMed ID: 31388072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CA-125 for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis.
    Zhao P; Yu Q; Zhang A; He F; Xu S; Chen L
    BMC Infect Dis; 2021 Oct; 21(1):1091. PubMed ID: 34688261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis.
    Ndzi EN; Nkenfou CN; Mekue LM; Zentilin L; Tamgue O; Pefura EWY; Kuiaté JR; Giacca M; Ndjolo A
    Tuberculosis (Edinb); 2019 Jan; 114():69-76. PubMed ID: 30711160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated circRNAs in plasma from active tuberculosis patients.
    Yi Z; Gao K; Li R; Fu Y
    J Cell Mol Med; 2018 Sep; 22(9):4076-4084. PubMed ID: 29961269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
    Sur D; Advani S; Braithwaite D
    Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
    Kang JW; Eun YG; Lee YC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of miR-29a in serum of patients with pulmonary tuberculosis and prediction of its function with bioinformatics analysis].
    Fu YR; Yi ZJ; Li JH; Gao KS
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):186-90. PubMed ID: 23856141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
    Wang H; Xu J; Ding L
    Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could microRNA be used as a diagnostic tool for lung cancer?
    Wang Y; Guan J; Wang Y
    J Cell Biochem; 2019 Nov; 120(11):18937-18945. PubMed ID: 31237019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential diagnostic value of circulating miRNA for multiple myeloma: A meta-analysis.
    Gao SS; Wang YJ; Zhang GX; Zhang WT
    J Bone Oncol; 2020 Dec; 25():100327. PubMed ID: 33145153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ​Meta-analysis of the applied value of the growth differentiation factor 15 detection in HFpEF diagnosis.
    Wang C; Gu Z; Guo Y
    Acta Cardiol; 2023 Dec; 78(10):1120-1128. PubMed ID: 37811648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy.
    Wagh V; Urhekar A; Modi D
    Tuberculosis (Edinb); 2017 Jan; 102():24-30. PubMed ID: 28061948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.